425: Strive CEO Posts on X.com Regarding Semler Merger

Strive, Inc. CEO Matthew Cole posted on X.com about the proposed business combination with Semler Scientific, Inc., emphasizing the ongoing process and associated risks.

Summary

• Strive, Inc. CEO Matthew Cole posted on X.com on December 4, 2025, regarding the proposed business combination with Semler Scientific, Inc.
• The communication is a Form 425 filing, serving as a legal disclosure related to the merger.
• It includes a cautionary statement about forward-looking statements, risks, and uncertainties associated with the transaction.
• Strive has filed a Registration Statement on Form S-4, which includes an Information Statement/Proxy Statement/Prospectus, to register Class A common stock to be issued in connection with the proposed transaction.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is a standard legal disclosure related to a proposed business combination, emphasizing the procedural steps and inherent risks of such a transaction. It does not contain new financial performance data or significant positive/negative operational updates, thus maintaining a neutral sentiment.

Positives

• The proposed transaction aims for strategic and financial benefits for the combined company, including expected impact on future financial performance.

Negatives

• The filing highlights numerous risks and uncertainties that could cause actual results to differ materially from anticipated outcomes, rather than detailing specific negative results.

Risks

• The occurrence of any event, change, or circumstance that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with Bitcoin and other digital assets, and problems arising from the implementation of Bitcoin treasury strategies.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction's success.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The filing includes forward-looking statements regarding the outlook and expectations of Strive and Semler Scientific concerning the proposed transaction, including anticipated strategic and financial benefits and the expected impact on the combined company's future financial performance. These statements are subject to inherent risks and uncertainties.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., posted the communication on X.com.

Industry Context

This announcement is a standard procedural step in a corporate merger, indicating progress in the business combination between Strive and Semler Scientific. The explicit mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests a strategic element related to digital asset exposure, which is a notable, albeit niche, trend in corporate treasury management, particularly for a company like Semler Scientific, which is primarily in the medical device sector. This implies a potential diversification or strategic shift for the combined entity.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a potential risk.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Shareholders of Semler Scientific will vote on the proposed transaction and will receive Strive stock if the merger is approved.
• Customers of both Strive and Semler Scientific may have adverse reactions to the announcement or completion of the transaction.
• Employee relationships at both companies could be affected by the announcement or completion of the transaction.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents with the SEC concerning the proposed transaction.
• The proposed transaction will close upon the satisfaction of all conditions.

Key Dates

Keywords

Strive, Semler Scientific, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Digital Assets, Corporate Governance